TY  - GEN
AU  - Akita,Keitaro
AU  - Inohara,Taku
AU  - Yamaji,Kyohei
AU  - Kohsaka,Shun
AU  - Numasawa,Yohei
AU  - Ishii,Hideki
AU  - Amano,Tetsuya
AU  - Kadota,Kazushige
AU  - Nakamura,Masato
AU  - Maekawa,Yuichiro
TI  - Impact of reduced-dose prasugrel vs. standard-dose clopidogrel on in-hospital outcomes of percutaneous coronary intervention in 62 737 patients with acute coronary syndromes: a nationwide registry study in Japan
SN  - 2055-6845
PY  - 2020///1201
KW  - Acute Coronary Syndrome
KW  - diagnosis
KW  - Aged
KW  - Aged, 80 and over
KW  - Clopidogrel
KW  - administration & dosage
KW  - Coronary Thrombosis
KW  - mortality
KW  - Databases, Factual
KW  - Female
KW  - Hemorrhage
KW  - chemically induced
KW  - Hospital Mortality
KW  - Hospitalization
KW  - Humans
KW  - Incidence
KW  - Japan
KW  - epidemiology
KW  - Male
KW  - Middle Aged
KW  - Percutaneous Coronary Intervention
KW  - adverse effects
KW  - Platelet Aggregation Inhibitors
KW  - Prasugrel Hydrochloride
KW  - Propensity Score
KW  - Prospective Studies
KW  - Registries
KW  - Risk Assessment
KW  - Risk Factors
KW  - ST Elevation Myocardial Infarction
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1093/ehjcvp/pvz056
ER  -